Pathology Associates Of Lexington, P.A.
Pathology Associates Of Lexington, P.A.
Pathology Associates Of Lexington, P.A.
 Home | Pathology Group MembersOur Hospital  Search This Website:
        MPI and MPA Index
      
MORPHOMETRIC PROGNOSTIC INDEX (MPI)
and MITOTIC ACTIVITY INDEX (MAI)

Study #1

Survival data on 211 premenopausal mastectomy patients 1969-1980
(all treated by modified radical mastectomy...those with central or medial primaries or with positive nodes also getting radiation)

Who needs early adjuvant chemotherapy (ACT)?

node-negative group

RFSrelapse/recurrence-free survival (5 years)

overall survival
(5 years)

MPI less than 0.60

83% (n=87 cases)

94%

MPI greater than 0.60

53% (n=34 cases)

65%

MPI greater than 0.0 58% (n=60 cases) 77%
MPI less than 0.0 90% (n=60 cases) 97%
(don't need ACT?)
MAI less than 10

94% (n=65 cases)

97%
(don't need ACT?)

MAI greater than 10

63% n=56 cases)

73%

node-positive group

RFSrelapse/recurrence-free survival (5 years)

overall survival
(5 years)

MPI less than 0.60

60% n=30 cases)

80%
MPI greater than 0.60 28% (n=60 cases) 45%
MPI greater than 0.0 35% (n=83 cases) 54%
MPI less than 0.0 86% (n=7 cases) 86%
MAI less than 10 63% (n=40 cases) 78%
MAI greater than 10 34% (n=50 cases) 40%
Reference: Baak, JPA, et. al., Human Pathology 22:326-336, 1991

Study #2

Special group of axillary lymph node positive patients with an improved prognosis (Eastern Cooperative Oncology Group
Companion Study EST 4189):

  • 368 eligible patients (in a total group of 560)

  • if MAI 0-2 mitoses per 10 40x hpfs, 5 year recurrence rate only 31% (RFS of 69%...a 6% advantage over MAI <10), as compared to:

  • if MAI greater than 2, 5 year recurrence rate is 52% (RFS of 48%)

Reference: David Page, et. al., Vanderbilt U. Dept. Pathology; J. Clin. Oncol. 18(10):2059-2069; May 2000.

From 23rd Annual San Antonio Breast Conference

6-9 Dec. 2000

  • Node negative, premenopausal: 543 patients without chemo, 8 yr follow-up

    • MAI less than 10: 19 of 310 (6.1%) died of cancer

    • MAI greater than 10: 66 of 233 (28.3%) died of cancer

  • Conclusion: the expected gain in lives saved is greatest in those node-negative cases with MAI >10 who are treated with ACT(adjuvant chemotherapy).

 
© Copyright 1999 - 2006, all rights reserved, Pathology Associates Of Lexington, P.A.